Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment - Lifestyle over and above drugs in diabetes (LOADD) study: Randomised controlled trial

BMJ (Online)

Volumn 341, Issue 7766, 2010, Pages 237-

  Coppell, Kirsten J ^a   Kataoka, Minako ^a   Williams, Sheila M ^a   Chisholm, Alex W ^a   Vorgers, Sue M ^a   Mann, Jim I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAT; HEMOGLOBIN A1C; HYPERTENSIVE AGENT; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CALORIC INTAKE; CEREAL; CLINICAL ASSESSMENT; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; DIETARY FIBER; DIETARY INTAKE; DYSLIPIDEMIA; FEMALE; FISH; FRUIT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTERVENTION STUDY; LEGUME; LIPID ANALYSIS; LOW FAT DIET; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MEAT; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; NUTRITIONAL REQUIREMENT; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; VEGETABLE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 77955105254     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3337     Document Type: Article

References (37)

1. Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlström B, Katsilambros N, et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004;14:373-94.
2. Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care 1986;9:168-72. (Pubitemid 16080472)
3. Truswell AS, Thomas BJ, Brown AM. Survey of dietary policy and management in British diabetic clinics. BMJ 1975;4:7-11.
4. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005;65:385-411. (Pubitemid 40227460)
5. Eliasson B, Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjö rnsdóttir S, for the Steering Committee of the Swedish National Diabetes Register (NDR). Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register. Diabetes Metab 2007;33:269-76.
6. Coppell K, Anderson K, Williams S, Manning P, Mann J. Evaluation of diabetes care in the Otago region using a diabetes register, 1998-2003. Diabetes Res Clin Pract 2006;71:345-52.
7. Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med 2009;169:1718-20.
8. Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B, for the Steering Committee of the Swedish National Diabetes Register. The National Diabetes Register in Sweden: an implementation of the St Vincent Declaration for quality improvement in diabetes care. Diabetes Care 2003;26:1270-6.
9. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-42. (Pubitemid 38101606)
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
11. Ruggiero L, Glasgow R, Dryfoos JM, Rossi JS, Prochaska JO, Orleans CT, et al. Diabetes self-management: self-reported recommendations and patterns in a large population. Diabetes Care 1997;20:568-76.
12. Rivellese AA, Boemi M, Cavalot F, Costagliola L, De Feo P, Miccoli R, et al. Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr 2008;62:660-4.
13. Gallwitz B, Häring HU. Future perspectives for insulinotropic agents in the treatment of type 2 diabetes - DPP-4 inhibitors and sulphonylureas. Diabetes Obes Metab 2010;12:1-11.
14. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, et al, for the 4-T Study Group. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009;361:1736-47.
15. Simpson HC, Simpson RW, Lousley S, Carter RD, Geekie M, Hockaday TD, et al. A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet 1981;1:1-5. (Pubitemid 11200325)
16. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.N Engl J Med 2000;342:1392-8.
17. New Zealand Guidelines Group. Management of type 2 diabetes. Ministry of Health and New Zealand Guidelines Group, 2003.
18. National Institute for Health and Clinical Excellence. Type 2 diabetes: the management of type 2 diabetes. NICE, 2008.
19. Clinical Guidelines Task Force. Global guideline for type 2 diabetes. International Diabetes Federation, 2005.
20. Bauman A, McLean G, Hurdle D, Walker S, Boyd J, van Aalst I, et al. Evaluation of the national 'Push Play' campaign in New Zealand - creating population awareness of physical activity. N ZMed J 2003;116:U535.
21. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-4.
22. Coppell K, Manning P. Establishing a regional diabetes register and a description of the registered population after one year. N Z Med J 2002;115:U146.
23. Wolf AM, Conaway MR, Crowther JQ, Hazen KY, L Nadler J, Oneida B, et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. Diabetes Care 2004;27:1570-6. (Pubitemid 38857428)
24. Clar C, Royle P, Waugh N. Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis. PLoS One 2009;4:e6112.
25. Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S. Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes. Diabetologia 2007;50:1148-55. (Pubitemid 46701545)
26. Hollander P, Yu D, Chou HS. Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes. Arch Intern Med 2007;167:1284-90.
27. Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
28. Perry TL, Mann JI, Lewis-Barned NJ, Duncan AW, Waldron MA, Thompson C. Lifestyle intervention in people with insulin-dependent diabetes mellitus (IDDM). Eur J Clin Nutr 1997;51:757-63. (Pubitemid 27485002)
29. Aas AM, Bergstad I, Thorsby PM, Johannesen O, Solberg M, Birkeland KI. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study. Diabet Med 2005;22:316-22.
30. Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE. Long-term effects of self-management education for patients with type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med 2004;21:491-6.
31. Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-83.
32. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
33. Ministry of Health. A portrait of health: key results of the 2006/07 New Zealand health survey. Ministry of Health, 2008.
34. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, 2007.
35. Funnell MM, Anderson RM. Working toward the next generation of diabetes self-management education. Am J Prev Med 2002;22(suppl 4):S3-5.
36. American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(suppl 1):S61-78.
37. Snoek F. Barriers to good glycaemic control: the patient's perspective. Int JObes Relat Metab Disord 2000;24(suppl 3):S12-20.